ES555353A0 - A PROCEDURE FOR PREPARING A LYOPHILIZED PHARMACEUTICAL FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR (T-PA) - Google Patents

A PROCEDURE FOR PREPARING A LYOPHILIZED PHARMACEUTICAL FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR (T-PA)

Info

Publication number
ES555353A0
ES555353A0 ES555353A ES555353A ES555353A0 ES 555353 A0 ES555353 A0 ES 555353A0 ES 555353 A ES555353 A ES 555353A ES 555353 A ES555353 A ES 555353A ES 555353 A0 ES555353 A0 ES 555353A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical formulation
plasminogen activator
tissue plasminogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555353A
Other languages
Spanish (es)
Other versions
ES8800601A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521705A external-priority patent/GB8521705D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES555353A0 publication Critical patent/ES555353A0/en
Publication of ES8800601A1 publication Critical patent/ES8800601A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES555353A 1985-05-28 1986-05-27 Solid hydrochloride salt of t-PA Expired ES8800601A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (2)

Publication Number Publication Date
ES555353A0 true ES555353A0 (en) 1987-11-16
ES8800601A1 ES8800601A1 (en) 1987-11-16

Family

ID=26289290

Family Applications (2)

Application Number Title Priority Date Filing Date
ES555353A Expired ES8800601A1 (en) 1985-05-28 1986-05-27 Solid hydrochloride salt of t-PA
ES557374A Expired ES8802439A1 (en) 1985-05-28 1987-02-10 Solid hydrochloride salt of t-PA

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557374A Expired ES8802439A1 (en) 1985-05-28 1987-02-10 Solid hydrochloride salt of t-PA

Country Status (22)

Country Link
US (2) US4929444A (en)
JP (1) JPH0759517B2 (en)
AU (1) AU567236B2 (en)
BE (1) BE904830A (en)
CA (1) CA1300008C (en)
CH (1) CH665356A5 (en)
DE (1) DE3617752A1 (en)
DK (1) DK163173C (en)
ES (2) ES8800601A1 (en)
FI (1) FI85335C (en)
FR (1) FR2583984B1 (en)
GB (1) GB2176702B (en)
GR (1) GR861366B (en)
HU (1) HU195733B (en)
IL (1) IL78938A (en)
IT (1) IT1191926B (en)
LU (1) LU86444A1 (en)
NL (1) NL8601355A (en)
NO (1) NO171345C (en)
NZ (1) NZ216307A (en)
PT (1) PT82646B (en)
SE (1) SE462016B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391812B (en) * 1985-05-28 1990-12-10 Wellcome Found METHOD FOR PRODUCING A PARENTERAL T-PA SOLUTION
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
NL8701113A (en) * 1986-05-12 1987-12-01 Wellcome Found NEW PHARMACEUTICAL APPLICATION.
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3835350A1 (en) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh ACTIVATION OF GENETICALLY MANUFACTURED ANTIBODY EXPRESSED IN PROKARYONS
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (en) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh STABILIZATION OF GLYCOSYLATED T-PA
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
AU710612B2 (en) * 1995-12-13 1999-09-23 Abbvie Inc. Endothelial cell proliferation inhibitor and method of use
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
CZ117798A3 (en) * 1995-10-23 1998-08-12 The Children's Medical Center Corporation Antiangiogenic composition and therapeutic methods
DK0827751T3 (en) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medical preparation containing tissue plasminogen activator and nicotinamide
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
US20040091465A1 (en) * 2002-06-26 2004-05-13 Zachary Yim Therapeutic antiangiogenic compositions and methods
US20050053980A1 (en) * 2003-06-20 2005-03-10 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
AU2006236150A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (en) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (en) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Manufacture of a plasminogen activator
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS5951220A (en) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd Novel plasminogen-activator, its preparation and drug containing the same
WO1984001714A1 (en) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59196824A (en) * 1983-04-21 1984-11-08 Kowa Co Adsorption inhibitor
DE3584902D1 (en) * 1984-02-29 1992-01-30 Asahi Chemical Ind AQUEOUS SOLUTION OF AN INCREASED CONCENTRATION OF TISSUE PLASMINOGEN ACTIVATOR AND PRODUCTION METHOD.
DE3439980A1 (en) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg METHOD FOR CLEANING AND PASTEURIZING UROKINASE
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (en) * 1985-10-02 1994-09-14 持田製薬株式会社 Thrombolytic agent and manufacturing method thereof

Also Published As

Publication number Publication date
IT1191926B (en) 1988-03-31
IL78938A (en) 1993-02-21
IT8648065A0 (en) 1986-05-27
GB8612780D0 (en) 1986-07-02
DE3617752A1 (en) 1986-12-04
BE904830A (en) 1986-11-27
HUT41638A (en) 1987-05-28
US4968617A (en) 1990-11-06
FR2583984A1 (en) 1987-01-02
FI862227A0 (en) 1986-05-27
NO171345B (en) 1992-11-23
DK163173C (en) 1992-06-22
ES8802439A1 (en) 1988-06-01
US4929444A (en) 1990-05-29
SE8602405D0 (en) 1986-05-27
PT82646B (en) 1989-01-30
JPH06183995A (en) 1994-07-05
FI85335B (en) 1991-12-31
GB2176702A (en) 1987-01-07
HU195733B (en) 1988-07-28
DK246786A (en) 1986-11-29
GB2176702B (en) 1989-07-05
FR2583984B1 (en) 1989-06-02
DE3617752C2 (en) 1988-06-30
ES557374A0 (en) 1988-06-01
ES8800601A1 (en) 1987-11-16
NO862096L (en) 1986-12-01
NL8601355A (en) 1986-12-16
PT82646A (en) 1986-06-01
FI862227A (en) 1986-11-29
SE8602405L (en) 1986-11-29
CH665356A5 (en) 1988-05-13
JPH0759517B2 (en) 1995-06-28
IL78938A0 (en) 1986-09-30
LU86444A1 (en) 1986-12-05
FI85335C (en) 1992-04-10
SE462016B (en) 1990-04-30
GR861366B (en) 1986-09-29
DK163173B (en) 1992-02-03
NZ216307A (en) 1989-10-27
AU5796486A (en) 1986-12-04
NO171345C (en) 1993-03-03
CA1300008C (en) 1992-05-05
AU567236B2 (en) 1987-11-12
DK246786D0 (en) 1986-05-27

Similar Documents

Publication Publication Date Title
ES555353A0 (en) A PROCEDURE FOR PREPARING A LYOPHILIZED PHARMACEUTICAL FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR (T-PA)
NO171344C (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR
ES555289A0 (en) PROCEDURE FOR PREPARING AN EFFERVESCENT COMPOSITION OF RAPID DISSOLUTION OF A THERAPEUTIC AGENT
ES553651A0 (en) A PROCEDURE FOR PREPARING AN ACTIVATOR OF PLASMINOGEN.
MX17752A (en) PHARMACEUTICAL FORMULATIONS AND PROCEDURE FOR PREPARING THEM
EP0196920A3 (en) Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation
NO168988C (en) USE OF AN ARGININIUM-CONTAINED BUFFER FOR FORMULATION OF STABLE PHARMACEUTICAL PREPARATIONS CONTAINING HUMAN TISSUE PLASMINOGEN ACTIVATOR
DK282985A (en) S- (CARBAMOYL-PHENYLSELENYL) DERIVATIVES OF GLUTATHION AND OF AMINOMERCAPTOCARBOXYL ACIDS, PROCEDURES FOR PRODUCING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
ES539500A0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL LIQUID FORMULATION OF DOUBLE-COATED CONTROLLED RELEASE DOSAGE FORMS
AU2913589A (en) Method to solubilize tissue plasminogen activator
AU6180486A (en) Novel tissue plasminogen activator derivatives
DK163639C (en) SYNERGISTIC PHARMACEUTICAL MIXTURE OF TISSUE PLASMINOGEN ACTIVATOR AND A PROSTAGLANDIN, PHARMACEUTICAL PREPARATION CONTAINING THE MIXTURE AND USE OF THE MIXTURE FOR THE PREPARATION OF A MEDICINE AGAINST BLOOD CLAMPS
HUT44770A (en) Process for producing 6-phenoxymethyl-4-hydroxy-tetrahydropyran-2-one derivatives and pharmaceutical preparations comprising them as active substance
DE3776111D1 (en) PHARMACEUTICAL PREPARATIONS.
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
IL78450A0 (en) Agent containing tissue plasminogen activator(t-pa)
ES551634A0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION BASED ON 3-AMINOPROPOXIINDOLES
IL79521A0 (en) Pharmaceutical dosage unit of tissue plasminogen activator
ZA872694B (en) Tissue plasminogen activator(tpa)derivative and its preparation
IE883254L (en) Preparation of halogenated protease inhibitors
AU609337B2 (en) Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof
IE882534L (en) Peg complex of tissue plasminogen activator
AU608232C (en) Modified tissue plasminogen activator
ATE68975T1 (en) PHARMACEUTICAL PREPARATIONS USED FOR STIMULATION OF TEARS.
NO883663D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001